High factor VIII, Von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in Blacks and Whites

Ethnicity and Disease

Volumn 24, Issue 2, 2014, Pages 169-174

  Payne, Amanda B ^a   Miller, Connie H ^a   Hooper, W Craig ^a   Lally, Cathy ^b   Austin, Harland D ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Factor VIII; Fibrinogen; Venous thromboembolism; Von willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; FIBRINOGEN; VON WILLEBRAND FACTOR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLACK PERSON; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; HOUSEHOLD; HUMAN; HYPERTENSION; INCOME; KIDNEY DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK FACTOR; SURGERY; VENOUS THROMBOEMBOLISM;

AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR VIII; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; UNITED STATES; VENOUS THROMBOEMBOLISM; VON WILLEBRAND FACTOR;

EID: 84901316614     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4 Suppl):S495-501.
2. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379(9828):1835-1846.
3. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4-8. (Pubitemid 41289265)
4. Dahlback B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 2008;112(1):19-27.
5. Zakai NA, McClure LA. Racial differences in venous thromboembolism. J Thromb Haemost. 2011;9(10):1877-1882.
6. Dilley A, Austin H, Hooper WC, et al. Relation of three genetic traits to venous thrombosis in an African-American population. Am J Epidemiol. 1998;147(1):30-35. (Pubitemid 28034609)
7. Hooper WC. Venous thromboembolism in African-Americans: a literature-based commentary. Thromb Res. 2010;125(1):12-18.
8. Tsai AW, Cushman M, Rosamond WD, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med. 2002;113(8):636-642. (Pubitemid 36015799)
9. Teixeira Mello TB, Machado TF, Montavao SA, Ozello MC, Annichino-Bizzacchi JM. Assessing the coagulation factor levels, inherited thrombophilia, and ABO blood group on the risk for venous thrombosis among Brazilians. Clin Appl Thromb Hemost. 2009;15(4): 408-414.
10. Angchaisuksiri P, Atichartakarn V, Aryurachai K, et al. Risk factors of venous thromboembolism in thai patients. Int J Hematol. 2007;86(5):397-402.
11. Austin H, Hooper WC, Lally C, et al. Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. J Clin Epidemiol. 2000;53(10):997-1001.
12. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briet E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms - the Leiden Thrombophilia Study (LETS). Thromb Haemost. 1994;71(6):719-722.
13. O'Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost. 2000;83(1):10-13. (Pubitemid 30045468)
14. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345(8943):152-155.
15. Conlan MG, Folsom AR, Finch A, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost. 1993;70(3):380-385. (Pubitemid 23254660)
16. Miller CH, Dilley A, Richardson L, Hooper WC, Evatt BL. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African- American women. Am J Hematol. 2001; 67(2):125-129.
17. Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost. 2003; 1(1):80-87.
18. Clauss A. [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol. 1957;17(4):237-246.
19. Jenkins PV, Rawley O, Smith OP, O'Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012; 157(6):653-663.
20. Ryland JK, Lawrie AS, Mackie IJ, Machin SJ. Persistent high factor VIII activity leading to increased thrombin generation - a prospective cohort study. Thromb Res. 2012;129(4): 447-452.
21. Tichelaar V, Mulder A, Kluin-Nelemans H, Meijer K. The acute phase reaction explains only a part of initially elevated factor VIII:C levels: a prospective cohort study in patients with venous thrombosis. Thromb Res. 2012;129(2):183-186.
22. Campos M, Buchanan A, Yu F, et al. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study. Blood. 2012;119(8):1929-1934.